CRO Support for NCATS Bioanalytical Method Development

Ended Master IDIQ Awarded

Federal agency
Awardees
3
Task orders
1
Obligated
$347,500

Vehicle facts

Opportunity
  • N01TR172004 Solicitation number
Agency
Combined task order value
$347,500 Current and potential, with all options
Last date to order 100% complete
Shared ceiling 9% used
$3,912,150.00

IDV award and task order details come from SAM.gov/FPDS.

About this vehicle

The National Institutes of Health (NIH) awarded this Master IDIQ to the National Center for Advancing Translational Sciences (NCATS) Division of Preclinical Innovation on March 26, 2018, to support contract research organization (CRO) services for bioanalytical method development in support of small molecule and biologic drug candidates. The vehicle's last date to order was March 30, 2023, and ordering closed three years ago.

The vehicle carried a combined potential value of $348 thousand, fully obligated through a single delivery order issued to PPD Development LP on September 24, 2018. The task order's ceiling was $347.5 thousand, firm fixed price, with an ultimate completion date of November 24, 2020. No subsequent orders were placed, and no activity occurred after 2018. The vehicle is not available for new work.

This IDIQ functioned as a single-award vehicle in practice, with PPD Development LP as the sole awardee and NCATS as the sole customer agency. The work supported preclinical translational research aimed at advancing drug discovery methodologies and moving novel therapeutics toward external partners for clinical development. The vehicle carried no set-aside designation.

The minimal financial scale, single task order placement, and closure of the ordering period three years ago indicate that this vehicle has completed its intended lifecycle and is not a pursuit opportunity. BD professionals should focus on other active NIH and NCATS vehicles or anticipate successor instruments if the Division of Preclinical Innovation recompetes bioanalytical support services.

Description

The Division of Preclinical Innovation (DPI) at National Center for Advancing Translational Science (NCATS) conducts translational research in the area of human therapeutics development and aims to move small molecule and biologic drug candidates forward in the drug development pipeline to predetermined milestones, at which point, DPI will hand off the drug candidate to external partner(s) to bring the novel therapy to patients. In addition to developing new candidate drugs, DPI seeks to advance the entire field of drug discovery and development by encouraging scientific and technological innovations aimed at improving success rates in the crucial pre-clinical stage of drug development.

IDV awards

Awardee IDV award Awarded
PPD Development LP HHSN271201800007I
Sri International HHSN271201800008I
Bioserv Corporation HHSN271201800006I

Latest task orders

Task order Awardee Awarding agency Obligated Last action
PPD development LP:1106692 [18-007540] 75N95018F00001 PPD Development LP NIDA $347,500

Top awardees by obligations

Rank Awardee Obligated Share
1 PPD Development LP $347,500 100%

Top funding agencies by obligations

Rank Funding agency Obligated Share
1 Department of Health and Human Services $347,500 100%

Obligations by fiscal year

Fiscal year Obligated
FY2024 -$78,400
FY2023 -$17,000
FY2019 $78,400
FY2018 $364,500

Quick answers

What is the CRO Support for NCATS Bioanalytical Method Development contract vehicle?

CRO Support for NCATS Bioanalytical Method Development is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by National Institutes of Health (Department of Health and Human Services), awarded on March 26, 2018.

Which companies hold CRO Support for NCATS Bioanalytical Method Development?

3 companies hold CRO Support for NCATS Bioanalytical Method Development's IDV awards, one each. The latest went to PPD Development LP on March 26, 2018. The awardees whose task orders obligated the most are PPD Development LP.

How much has been spent through CRO Support for NCATS Bioanalytical Method Development?

1 task order has been placed under CRO Support for NCATS Bioanalytical Method Development, obligating $347,500.

What is the shared ceiling of CRO Support for NCATS Bioanalytical Method Development?

CRO Support for NCATS Bioanalytical Method Development's shared ceiling is $3,912,150; its task orders have used 9% of it.

Which agencies use CRO Support for NCATS Bioanalytical Method Development the most?

The departments whose task orders under CRO Support for NCATS Bioanalytical Method Development obligated the most are Department of Health and Human Services ($347,500).

On GovTribe

See this vehicle's full record

  • Every IDV award and task order
  • Funding by agency, awardee, NAICS and set-aside
  • Teaming partners on this vehicle
  • Ask GovTribe AI about this vehicle